HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,592 | +77.6% | 6,400 | +100.0% | 0.00% | – |
| Q2 2023 | $3,712 | +75.6% | 3,200 | +128.6% | 0.00% | – |
| Q1 2023 | $2,114 | -39.6% | 1,400 | 0.0% | 0.00% | – |
| Q4 2022 | $3,500 | -41.7% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $6,000 | +50.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -38.5% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | -13.3% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -31.8% | 1,400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $22,000 | -4.3% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $23,000 | -23.3% | 1,400 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $30,000 | +42.9% | 1,400 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $21,000 | 0.0% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $21,000 | +31.2% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |